FDA.reportPublic FDA data

Olumiant 2 MG Oral Tablet

RxCUI
2047247
RxNorm name
Olumiant 2 MG Oral Tablet
Display name
Olumiant 2 MG Oral Tablet
Full name
Olumiant 2 MG Oral Tablet
Term type
PSN
Status
DailyMed mapping
Updated
2026-06-04 23:39:07

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
866e9f35-9035-4581-a4b1-75a621ab55cfOlumiant 2 MG Oral Tablet [PSN] · baricitinib 2 MG Oral Tablet [Olumiant] [SBD] · Olumiant 2 MG Oral Tablet [SY]328These highlights do not include all the information needed to use OLUMIANT safely and effectively. See full prescribing information for OLUMIANT. OLUMIANT (baricitinib) tablets, for oral use Initial U.S. Approval: 201820260422